APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydrocortisone Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hydrocortisone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchHydrocortisone Injection Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydrocortisone Injection Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Hydrocortisone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydrocortisone Injection Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydrocortisone Injection Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Hydrocortisone Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hydrocortisone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydrocortisone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydrocortisone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hydrocortisone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydrocortisone Injection include Southwest Pharmaceutical, KINGYOR, Shiyao YINHU Pharmaceutical, CSPC Ouyi Pharmaceutical, Maanshan Fengyuan Pharmaceutical, Jiangsu Lianhuan Pharmaceutical, Jiangsu Kangbao Pharmaceutical, Pfizer and HUAZHONG Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydrocortisone Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydrocortisone Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydrocortisone Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydrocortisone Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydrocortisone Injection Segment by Company

Southwest Pharmaceutical

KINGYOR

Shiyao YINHU Pharmaceutical

CSPC Ouyi Pharmaceutical

Maanshan Fengyuan Pharmaceutical

Jiangsu Lianhuan Pharmaceutical

Jiangsu Kangbao Pharmaceutical

Pfizer

HUAZHONG Pharmaceutical

Hubei Zhongjiachem Pharmaceutical

Hebei Tiancheng Pharmaceutical

Dalian Holley Kingkong Pharmaceutical

Chengdu No.1 Pharmaceutical

BIOZEN Pharmaceutical

Anhui Changjiang Pharmaceutical

Anhui Chengshi Pharmaceutical

Hydrocortisone Injection Segment by Type

Intramuscular Injection

Intravenous Drip

Hydrocortisone Injection Segment by Application

Hospital

Clinics

Other

Hydrocortisone Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydrocortisone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydrocortisone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydrocortisone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydrocortisone Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydrocortisone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hydrocortisone Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hydrocortisone Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hydrocortisone Injection Industry Trends Table 2. Hydrocortisone Injection Industry Drivers Table 3. Hydrocortisone Injection Industry Opportunities and Challenges Table 4. Hydrocortisone Injection Industry Restraints Table 5. Global Hydrocortisone Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hydrocortisone Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hydrocortisone Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Hydrocortisone Injection Sales Market Share by Manufacturers Table 9. Global Hydrocortisone Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Hydrocortisone Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hydrocortisone Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hydrocortisone Injection Manufacturers, Product Type & Application Table 13. Global Hydrocortisone Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydrocortisone Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Intramuscular Injection Table 17. Major Manufacturers of Intravenous Drip Table 18. Global Hydrocortisone Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Hydrocortisone Injection Sales by Type (2021-2026) & (k units) Table 20. Global Hydrocortisone Injection Sales by Type (2027-2032) & (k units) Table 21. Global Hydrocortisone Injection Sales Market Share by Type (2021-2026) Table 22. Global Hydrocortisone Injection Sales Market Share by Type (2027-2032) Table 23. Global Hydrocortisone Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Hydrocortisone Injection Revenue by Type (2021-2026) & (k units) Table 25. Global Hydrocortisone Injection Revenue by Type (2027-2032) & (k units) Table 26. Global Hydrocortisone Injection Revenue Market Share by Type (2021-2026) Table 27. Global Hydrocortisone Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Other Table 31. Global Hydrocortisone Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Hydrocortisone Injection Sales by Application (2021-2026) & (k units) Table 33. Global Hydrocortisone Injection Sales by Application (2027-2032) & (k units) Table 34. Global Hydrocortisone Injection Sales Market Share by Application (2021-2026) Table 35. Global Hydrocortisone Injection Sales Market Share by Application (2027-2032) Table 36. Global Hydrocortisone Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Hydrocortisone Injection Revenue by Application (2021-2026) & (k units) Table 38. Global Hydrocortisone Injection Revenue by Application (2027-2032) & (k units) Table 39. Global Hydrocortisone Injection Revenue Market Share by Application (2021-2026) Table 40. Global Hydrocortisone Injection Revenue Market Share by Application (2027-2032) Table 41. Global Hydrocortisone Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Hydrocortisone Injection Sales by Region (2021-2026) & (k units) Table 43. Global Hydrocortisone Injection Sales Market Share by Region (2021-2026) Table 44. Global Hydrocortisone Injection Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Hydrocortisone Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Hydrocortisone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Hydrocortisone Injection Sales by Country (2021-2026) & (k units) Table 48. North America Hydrocortisone Injection Sales by Country (2027-2032) & (k units) Table 49. Europe Hydrocortisone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Hydrocortisone Injection Sales by Country (2021-2026) & (k units) Table 51. Europe Hydrocortisone Injection Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Hydrocortisone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Hydrocortisone Injection Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Hydrocortisone Injection Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Hydrocortisone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Hydrocortisone Injection Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Hydrocortisone Injection Sales by Country (2027-2032) & (k units) Table 58. Global Hydrocortisone Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hydrocortisone Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Hydrocortisone Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Hydrocortisone Injection Revenue Market Share by Region (2021-2026) Table 62. Global Hydrocortisone Injection Revenue Market Share by Region (2027-2032) Table 63. Southwest Pharmaceutical Company Information Table 64. Southwest Pharmaceutical Business Overview Table 65. Southwest Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Southwest Pharmaceutical Hydrocortisone Injection Product Portfolio Table 67. Southwest Pharmaceutical Recent Development Table 68. KINGYOR Company Information Table 69. KINGYOR Business Overview Table 70. KINGYOR Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. KINGYOR Hydrocortisone Injection Product Portfolio Table 72. KINGYOR Recent Development Table 73. Shiyao YINHU Pharmaceutical Company Information Table 74. Shiyao YINHU Pharmaceutical Business Overview Table 75. Shiyao YINHU Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shiyao YINHU Pharmaceutical Hydrocortisone Injection Product Portfolio Table 77. Shiyao YINHU Pharmaceutical Recent Development Table 78. CSPC Ouyi Pharmaceutical Company Information Table 79. CSPC Ouyi Pharmaceutical Business Overview Table 80. CSPC Ouyi Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CSPC Ouyi Pharmaceutical Hydrocortisone Injection Product Portfolio Table 82. CSPC Ouyi Pharmaceutical Recent Development Table 83. Maanshan Fengyuan Pharmaceutical Company Information Table 84. Maanshan Fengyuan Pharmaceutical Business Overview Table 85. Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Product Portfolio Table 87. Maanshan Fengyuan Pharmaceutical Recent Development Table 88. Jiangsu Lianhuan Pharmaceutical Company Information Table 89. Jiangsu Lianhuan Pharmaceutical Business Overview Table 90. Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Product Portfolio Table 92. Jiangsu Lianhuan Pharmaceutical Recent Development Table 93. Jiangsu Kangbao Pharmaceutical Company Information Table 94. Jiangsu Kangbao Pharmaceutical Business Overview Table 95. Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Product Portfolio Table 97. Jiangsu Kangbao Pharmaceutical Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Pfizer Hydrocortisone Injection Product Portfolio Table 102. Pfizer Recent Development Table 103. HUAZHONG Pharmaceutical Company Information Table 104. HUAZHONG Pharmaceutical Business Overview Table 105. HUAZHONG Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. HUAZHONG Pharmaceutical Hydrocortisone Injection Product Portfolio Table 107. HUAZHONG Pharmaceutical Recent Development Table 108. Hubei Zhongjiachem Pharmaceutical Company Information Table 109. Hubei Zhongjiachem Pharmaceutical Business Overview Table 110. Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Product Portfolio Table 112. Hubei Zhongjiachem Pharmaceutical Recent Development Table 113. Hebei Tiancheng Pharmaceutical Company Information Table 114. Hebei Tiancheng Pharmaceutical Business Overview Table 115. Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Product Portfolio Table 117. Hebei Tiancheng Pharmaceutical Recent Development Table 118. Dalian Holley Kingkong Pharmaceutical Company Information Table 119. Dalian Holley Kingkong Pharmaceutical Business Overview Table 120. Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Product Portfolio Table 122. Dalian Holley Kingkong Pharmaceutical Recent Development Table 123. Chengdu No.1 Pharmaceutical Company Information Table 124. Chengdu No.1 Pharmaceutical Business Overview Table 125. Chengdu No.1 Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Chengdu No.1 Pharmaceutical Hydrocortisone Injection Product Portfolio Table 127. Chengdu No.1 Pharmaceutical Recent Development Table 128. BIOZEN Pharmaceutical Company Information Table 129. BIOZEN Pharmaceutical Business Overview Table 130. BIOZEN Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. BIOZEN Pharmaceutical Hydrocortisone Injection Product Portfolio Table 132. BIOZEN Pharmaceutical Recent Development Table 133. Anhui Changjiang Pharmaceutical Company Information Table 134. Anhui Changjiang Pharmaceutical Business Overview Table 135. Anhui Changjiang Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Anhui Changjiang Pharmaceutical Hydrocortisone Injection Product Portfolio Table 137. Anhui Changjiang Pharmaceutical Recent Development Table 138. Anhui Chengshi Pharmaceutical Company Information Table 139. Anhui Chengshi Pharmaceutical Business Overview Table 140. Anhui Chengshi Pharmaceutical Hydrocortisone Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Anhui Chengshi Pharmaceutical Hydrocortisone Injection Product Portfolio Table 142. Anhui Chengshi Pharmaceutical Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Hydrocortisone Injection Distributors List Table 146. Hydrocortisone Injection Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Hydrocortisone Injection Product Image Figure 2. Global Hydrocortisone Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydrocortisone Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydrocortisone Injection Sales (2021-2032) & (k units) Figure 5. Global Hydrocortisone Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hydrocortisone Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Intramuscular Injection Image Figure 9. Intravenous Drip Image Figure 10. Global Hydrocortisone Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Hydrocortisone Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hydrocortisone Injection Sales Market Share by Type (2021-2032) Figure 13. Global Hydrocortisone Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Hydrocortisone Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hydrocortisone Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinics Image Figure 18. Other Image Figure 19. Global Hydrocortisone Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Hydrocortisone Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Hydrocortisone Injection Sales Market Share by Application (2021-2032) Figure 22. Global Hydrocortisone Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Hydrocortisone Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Hydrocortisone Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Hydrocortisone Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Hydrocortisone Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Hydrocortisone Injection Sales Market Share by Country (2021-2032) Figure 39. China Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Hydrocortisone Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Hydrocortisone Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Hydrocortisone Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Hydrocortisone Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Hydrocortisone Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Hydrocortisone Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Hydrocortisone Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Hydrocortisone Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hydrocortisone Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Hydrocortisone Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Hydrocortisone Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Hydrocortisone Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hydrocortisone Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Hydrocortisone Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Injection
  • Intravenous Drip
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • Southwest Pharmaceutical
  • KINGYOR
  • Shiyao YINHU Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Maanshan Fengyuan Pharmaceutical
  • Jiangsu Lianhuan Pharmaceutical
  • Jiangsu Kangbao Pharmaceutical
  • Pfizer
  • HUAZHONG Pharmaceutical
  • Hubei Zhongjiachem Pharmaceutical
  • Hebei Tiancheng Pharmaceutical
  • Dalian Holley Kingkong Pharmaceutical
  • Chengdu No.1 Pharmaceutical
  • BIOZEN Pharmaceutical
  • Anhui Changjiang Pharmaceutical
  • Anhui Chengshi Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hydrocortisone Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hydrocortisone Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hydrocortisone Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hydrocortisone Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hydrocortisone Injection Market Dynamics
  1. 2.1 Hydrocortisone Injection Industry Trends
  2. 2.2 Hydrocortisone Injection Industry Drivers
  3. 2.3 Hydrocortisone Injection Industry Opportunities and Challenges
  4. 2.4 Hydrocortisone Injection Industry Restraints
3 Hydrocortisone Injection Market by Manufacturers
  1. 3.1 Global Hydrocortisone Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hydrocortisone Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hydrocortisone Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hydrocortisone Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydrocortisone Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hydrocortisone Injection Manufacturers, Product Type & Application
  7. 3.7 Global Hydrocortisone Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydrocortisone Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydrocortisone Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydrocortisone Injection Tier 1, Tier 2, and Tier 3
4 Hydrocortisone Injection Market by Type
  1. 4.1 Hydrocortisone Injection Type Introduction
  2. 4.1.1 Intramuscular Injection
  3. 4.1.2 Intravenous Drip
  4. 4.2 Global Hydrocortisone Injection Sales by Type
  5. 4.2.1 Global Hydrocortisone Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hydrocortisone Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Hydrocortisone Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hydrocortisone Injection Revenue by Type
  9. 4.3.1 Global Hydrocortisone Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hydrocortisone Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Hydrocortisone Injection Revenue Market Share by Type (2021-2032)
5 Hydrocortisone Injection Market by Application
  1. 5.1 Hydrocortisone Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Hydrocortisone Injection Sales by Application
  6. 5.2.1 Global Hydrocortisone Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hydrocortisone Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Hydrocortisone Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hydrocortisone Injection Revenue by Application
  10. 5.3.1 Global Hydrocortisone Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hydrocortisone Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Hydrocortisone Injection Revenue Market Share by Application (2021-2032)
6 Global Hydrocortisone Injection Sales by Region
  1. 6.1 Global Hydrocortisone Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydrocortisone Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Hydrocortisone Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Hydrocortisone Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hydrocortisone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hydrocortisone Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hydrocortisone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hydrocortisone Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hydrocortisone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hydrocortisone Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hydrocortisone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hydrocortisone Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hydrocortisone Injection Revenue by Region
  1. 7.1 Global Hydrocortisone Injection Revenue by Region
  2. 7.1.1 Global Hydrocortisone Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hydrocortisone Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Hydrocortisone Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Hydrocortisone Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hydrocortisone Injection Revenue (2021-2032)
  8. 7.2.2 North America Hydrocortisone Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hydrocortisone Injection Revenue (2021-2032)
  11. 7.3.2 Europe Hydrocortisone Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hydrocortisone Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hydrocortisone Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hydrocortisone Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hydrocortisone Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Southwest Pharmaceutical
  2. 8.1.1 Southwest Pharmaceutical Company Information
  3. 8.1.2 Southwest Pharmaceutical Business Overview
  4. 8.1.3 Southwest Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Southwest Pharmaceutical Hydrocortisone Injection Product Portfolio
  6. 8.1.5 Southwest Pharmaceutical Recent Developments
  7. 8.2 KINGYOR
  8. 8.2.1 KINGYOR Company Information
  9. 8.2.2 KINGYOR Business Overview
  10. 8.2.3 KINGYOR Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 KINGYOR Hydrocortisone Injection Product Portfolio
  12. 8.2.5 KINGYOR Recent Developments
  13. 8.3 Shiyao YINHU Pharmaceutical
  14. 8.3.1 Shiyao YINHU Pharmaceutical Company Information
  15. 8.3.2 Shiyao YINHU Pharmaceutical Business Overview
  16. 8.3.3 Shiyao YINHU Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shiyao YINHU Pharmaceutical Hydrocortisone Injection Product Portfolio
  18. 8.3.5 Shiyao YINHU Pharmaceutical Recent Developments
  19. 8.4 CSPC Ouyi Pharmaceutical
  20. 8.4.1 CSPC Ouyi Pharmaceutical Company Information
  21. 8.4.2 CSPC Ouyi Pharmaceutical Business Overview
  22. 8.4.3 CSPC Ouyi Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CSPC Ouyi Pharmaceutical Hydrocortisone Injection Product Portfolio
  24. 8.4.5 CSPC Ouyi Pharmaceutical Recent Developments
  25. 8.5 Maanshan Fengyuan Pharmaceutical
  26. 8.5.1 Maanshan Fengyuan Pharmaceutical Company Information
  27. 8.5.2 Maanshan Fengyuan Pharmaceutical Business Overview
  28. 8.5.3 Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Product Portfolio
  30. 8.5.5 Maanshan Fengyuan Pharmaceutical Recent Developments
  31. 8.6 Jiangsu Lianhuan Pharmaceutical
  32. 8.6.1 Jiangsu Lianhuan Pharmaceutical Company Information
  33. 8.6.2 Jiangsu Lianhuan Pharmaceutical Business Overview
  34. 8.6.3 Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Product Portfolio
  36. 8.6.5 Jiangsu Lianhuan Pharmaceutical Recent Developments
  37. 8.7 Jiangsu Kangbao Pharmaceutical
  38. 8.7.1 Jiangsu Kangbao Pharmaceutical Company Information
  39. 8.7.2 Jiangsu Kangbao Pharmaceutical Business Overview
  40. 8.7.3 Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Product Portfolio
  42. 8.7.5 Jiangsu Kangbao Pharmaceutical Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Hydrocortisone Injection Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 HUAZHONG Pharmaceutical
  50. 8.9.1 HUAZHONG Pharmaceutical Company Information
  51. 8.9.2 HUAZHONG Pharmaceutical Business Overview
  52. 8.9.3 HUAZHONG Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HUAZHONG Pharmaceutical Hydrocortisone Injection Product Portfolio
  54. 8.9.5 HUAZHONG Pharmaceutical Recent Developments
  55. 8.10 Hubei Zhongjiachem Pharmaceutical
  56. 8.10.1 Hubei Zhongjiachem Pharmaceutical Company Information
  57. 8.10.2 Hubei Zhongjiachem Pharmaceutical Business Overview
  58. 8.10.3 Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Product Portfolio
  60. 8.10.5 Hubei Zhongjiachem Pharmaceutical Recent Developments
  61. 8.11 Hebei Tiancheng Pharmaceutical
  62. 8.11.1 Hebei Tiancheng Pharmaceutical Company Information
  63. 8.11.2 Hebei Tiancheng Pharmaceutical Business Overview
  64. 8.11.3 Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Product Portfolio
  66. 8.11.5 Hebei Tiancheng Pharmaceutical Recent Developments
  67. 8.12 Dalian Holley Kingkong Pharmaceutical
  68. 8.12.1 Dalian Holley Kingkong Pharmaceutical Company Information
  69. 8.12.2 Dalian Holley Kingkong Pharmaceutical Business Overview
  70. 8.12.3 Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Product Portfolio
  72. 8.12.5 Dalian Holley Kingkong Pharmaceutical Recent Developments
  73. 8.13 Chengdu No.1 Pharmaceutical
  74. 8.13.1 Chengdu No.1 Pharmaceutical Company Information
  75. 8.13.2 Chengdu No.1 Pharmaceutical Business Overview
  76. 8.13.3 Chengdu No.1 Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Chengdu No.1 Pharmaceutical Hydrocortisone Injection Product Portfolio
  78. 8.13.5 Chengdu No.1 Pharmaceutical Recent Developments
  79. 8.14 BIOZEN Pharmaceutical
  80. 8.14.1 BIOZEN Pharmaceutical Company Information
  81. 8.14.2 BIOZEN Pharmaceutical Business Overview
  82. 8.14.3 BIOZEN Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BIOZEN Pharmaceutical Hydrocortisone Injection Product Portfolio
  84. 8.14.5 BIOZEN Pharmaceutical Recent Developments
  85. 8.15 Anhui Changjiang Pharmaceutical
  86. 8.15.1 Anhui Changjiang Pharmaceutical Company Information
  87. 8.15.2 Anhui Changjiang Pharmaceutical Business Overview
  88. 8.15.3 Anhui Changjiang Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Anhui Changjiang Pharmaceutical Hydrocortisone Injection Product Portfolio
  90. 8.15.5 Anhui Changjiang Pharmaceutical Recent Developments
  91. 8.16 Anhui Chengshi Pharmaceutical
  92. 8.16.1 Anhui Chengshi Pharmaceutical Company Information
  93. 8.16.2 Anhui Chengshi Pharmaceutical Business Overview
  94. 8.16.3 Anhui Chengshi Pharmaceutical Hydrocortisone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Anhui Chengshi Pharmaceutical Hydrocortisone Injection Product Portfolio
  96. 8.16.5 Anhui Chengshi Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydrocortisone Injection Value Chain Analysis
  2. 9.1.1 Hydrocortisone Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydrocortisone Injection Production Mode & Process
  6. 9.2 Hydrocortisone Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydrocortisone Injection Distributors
  9. 9.2.3 Hydrocortisone Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst